These encouraging results mean that prospective trials are needed to determine whether GLP-1 receptor agonists can be repurposed as gerotherapeutics, say the authors
GLP-1 medications are unsuitable for individuals with: A personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia type 2 (MEN 2) They should also be used with caution in patients with severe gastrointestinal disease
Impurities generated from asparagine at position 7 (Asn7) account for 62% of all degradation impurities and are the most critical factor affecting stability
The peptides used in regenerative medicine clinics across South Florida work through entirely different pathways, targeting fat metabolism, growth hormone secretion, and cellular energy directly
Learn more about weight management with diabetes here:
Additionally, despite substantial weight loss, systematic cardiovascular outcomes trials have not been completed to establish whether GLP3 reduces major adverse cardiovascular events